Table 1.
Sample Demographics
| Variable | Waitlist Sample | MBCT Sample |
|---|---|---|
| Total Enrolled | 19 | 24 |
| Sex, n (%), girls | 13(68) | 18(75) |
| Age, n (%) | ||
| 9 | 2(11) | 2(8) |
| 10 | 2(11) | 3(13) |
| 11 | 0(0) | 0(0) |
| 12 | 2(11) | 2(8) |
| 13 | 1(5) | 2(8) |
| 14 | 2(11) | 5(21) |
| 15 | 5(26) | 5(21) |
| 16 | 1(5) | 1(4) |
| 17 | 3(16) | 3(13) |
| 18 | 1(5) | 1(4) |
| Race, n (%) | ||
| White | 16(84) | 19(79) |
| Anxiety Disorders,a n (%) | ||
| Generalized Anxiety Disorder | 18(95) | 22(92) |
| Social Anxiety Disorders | 5(26) | 9(38) |
| Separation Anxiety | 3(16) | 3(13) |
| Specific Phobias | 3(16) | 3(13) |
| Panic Disorder with Agoraphobia | 1(5) | 1(4) |
| Obsessive Compulsive Disorder | 1(5) | 1(4) |
| Concomitant medications, n (%) | ||
| Stimulant | 3(16) | 5(21) |
| Antidepressant | 8(42) | 10(42) |
| Supplementb | 3(16) | 5(21) |
| Concomitant psychotherapy, n (%) | 6(32) | 8(33) |
Note.
a
Some participants had multiple anxiety diagnoses
b
Supplements included melatonin, omega-3, vitamin D, iron, and magnesium. Percentages may not add up to 100 due to rounding. The 19 in the waitlist period are the same participants in the MBCT period, plus an additional 5 participants that did not complete the waitlist period.